Menu
Back to User profile » Professor Michele Fornaro
Papers published by Professor Michele Fornaro:
Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review
Solmi M, Murru A, Pacchiarotti I, Undurraga J, Veronese N, Fornaro M, Stubbs B, Monaco F, Vieta E, Seeman MV, Correll CU, Carvalho AF
Therapeutics and Clinical Risk Management 2017, 13:757-777
Published Date: 29 June 2017
Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trials
Fornaro M, Solmi M, Perna G, De Berardis D, Veronese N, Orsolini L, Ganança L, Stubbs B
Neuropsychiatric Disease and Treatment 2016, 12:1827-1836
Published Date: 25 July 2016
Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review
Fornaro M, De Berardis D, Koshy AS, Perna G, Valchera A, Vancampfort D, Stubbs B
Neuropsychiatric Disease and Treatment 2016, 12:719-735
Published Date: 31 March 2016
The role of melatonin in mood disorders
De Berardis D, Orsolini L, Serroni N, Girinelli G, Iasevoli F, Tomasetti C, Mazza M, Valchera A, Fornaro M, Perna G, Piersanti M, Di Nicola M, Cavuto M, Martinotti G, Di Giannantonio M
ChronoPhysiology and Therapy 2015, 5:65-75
Published Date: 11 November 2015
Cognitive functioning and subjective quality of life in relapsing-remitting multiple sclerosis patients before and after percutaneous transluminal angioplasty: a preliminary report
De Pasquale C, Pistorio ML, Veroux M, Giaquinta A, Veroux P, Fornaro M
Neuropsychiatric Disease and Treatment 2014, 10:1039-1044
Published Date: 11 June 2014
Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?
Fornaro M, Bandini F, Cestari L, Cordano C, Ogliastro C, Albano C, De Berardis D, Martino M, Escelsior A, Rocchi G, Fornaro P, De Pasquale C
Neuropsychiatric Disease and Treatment 2014, 10:907-914
Published Date: 20 May 2014
Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study
Fornaro M, McCarthy MJ, De Berardis D, De Pasquale C, Tabaton M, Martino M, Colicchio S, Cattaneo CI, D'Angelo E, Fornaro P
Neuropsychiatric Disease and Treatment 2013, 9:243-251
Published Date: 15 February 2013
Prevalence and diagnostic distribution of medically unexplained painful somatic symptoms across 571 major depressed outpatients
Fornaro M, Maremmani I, Canonico PL, Carbonatto P, Mencacci C, Muscettola G, Pani L, Torta R, Vampini C, Parazzini F, Dumitriu A, Perugi G
Neuropsychiatric Disease and Treatment 2011, 7:217-221
Published Date: 21 April 2011
Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation
Michele Fornaro, Matteo Martino, Florinda Battaglia, et al
Neuropsychiatric Disease and Treatment 2011, 7:51-56
Published Date: 10 February 2011
Obsessive-compulsive disorder with bipolar diathesis following isotretinoin therapy remitting upon treatment with olanzapine and fluvoxamine
Michele Fornaro
Neuropsychiatric Disease and Treatment 2010, 6:719-722
Published Date: 29 October 2010
Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management
Michele Fornaro, Matteo Martino
Neuropsychiatric Disease and Treatment 2010, 6:209-218
Published Date: 1 June 2010